Nucleofill: Polynucleotide Gels, Product Lines and CE Marking
You notice dryness and fine lines but do not want fuller cheekbones or a different facial expression. Someone may have suggested Nucleofill as a “biostimulator”. Nucleofill is a family of injectable polynucleotide-based gels associated with Promoitalia Group. It is mainly discussed for skin quality, not for lifting sagging tissues significantly or replacing a surgical facelift. Changes in hydration, texture and fine lines, if they occur, are assessed gradually; a universal lifting effect has not been proven.
In the Argentinian regulatory documentation, the versions concerned are classified as temporary fillers for minor skin defects. That is a regulatory description of these specific products, not a promise of substantial facial volume or lifting.
An essential detail is that Nucleofill has several formulas, and they are not interchangeable. You cannot choose by the word “Strong” alone or assume a formula intended for one area is suitable under the eyes. Before consenting, request the complete commercial name, up-to-date instructions for the exact package and a clear reason this formula is appropriate for your skin. A brand name on overseas marketing material does not establish local registration or availability in Armenia.
What is in it, and how is it supposed to work?
Polynucleotides (PN) are segments of nucleic acids, the building blocks of DNA chains. Products in this category often contain purified fish-derived material. Instructions for certain Nucleofill versions published by Argentina's regulator ANMAT describe a sterile, absorbable gel of polymerised animal-derived polynucleotides. The molecules' hydrophilic properties help retain water; their other biological effects on tissues are still being studied.
Marketing may speak of “bioregeneration”, “antioxidant effects” or “cellular lifting”. These describe proposed manufacturer mechanisms, not guaranteed clinical outcomes. Cell biology or laboratory markers cannot be converted directly into a promised number of wrinkles smoothed on your face. You might feel more comfortable and hydrated skin, or notice little beyond transient injection reactions. Do not mistake the temporary fullness of swelling for lasting improvement.
A 2025 systematic review of aesthetic PN injections included nine studies involving 219 people and judged the evidence low or moderate quality. Selected skin measurements showed promise, but robust large trials and standard protocols remain lacking. A 2026 review, searching the literature through January 2026, included seven randomised trials with 183 participants across skin rejuvenation, scar prevention and wound healing. Different formulas, treatment plans and outcome measures limit generalisation. Evidence about the PN/PDRN category does not prove that each Nucleofill version works for every advertised area.
How do Medium, Strong, Soft and zone-specific products differ?
Historical ANMAT documentation for Nucleofill Soft, Medium and Strong lists polynucleotide concentrations of 7.5, 20 and 25 mg/ml, respectively. Other markets and ranges feature additional names such as Soft Plus Eyes and Medium Plus Hair. Composition, concentration, syringe volume, intended treatment areas and restrictions may all differ. A similar label or a “2 ml” syringe does not mean two products have the same instructions.
For those same historical versions, ANMAT specifies a limit of no more than one 1.5 ml syringe per treatment area per session. This limit in the 2022 document must not automatically be applied to a different version or jurisdiction; the clinician must check the current instructions for the exact product used.
| Product label | What the cited sources establish | What to ask the clinician |
|---|---|---|
| Nucleofill Soft | ANMAT documents describe fine superficial wrinkles and small scars for this formula; 7.5 mg/ml | Is it really Soft, and is the intended site allowed? |
| Nucleofill Medium | The cited documents address some shallow wrinkles and scars; 20 mg/ml | What benefit is expected over ordinary moisturising skincare? |
| Nucleofill Strong | Those documents address more pronounced surface defects and certain body areas; 25 mg/ml | Why a higher concentration, and how might it affect risks? |
| Soft Plus Eyes, Medium Plus Hair and other variants | Separately marketed products; not equivalent to the three versions above | Are current instructions available for this specific product, treatment area and country? |
The eye area needs particular caution. The descriptive section of the published ANMAT document mentions the periocular area among potential sites, but the contraindications section of that same document explicitly prohibits Nucleofill injections around the eyes, including eyelids and under-eye tissues. Where one document conflicts with itself, a general list of sites cannot override an explicit prohibition; resolve the discrepancy against the current instructions for the exact product. A separately named Eyes variant is not automatically permitted in every country or technique. Decline “ordinary Strong under the eyes because its composition is similar”.
What do registration and the CE mark really mean?
A published 2022 ANMAT authorisation concerns particular Nucleofill products and their indications, formulas and restrictions on the Argentinian market. It is not Armenian registration. A CE mark appears in some promotional materials, but an advertisement alone, without a current declaration and relevant certificate, matching product identification and batch details, does not establish the present European regulatory status of that exact item. Do not describe the formulations discussed here as “FDA-approved”: no such product-specific authorisation is established by the evidence cited.
Before injection, the clinician should show you the intact sterile packaging, manufacturer, expiry date, precise product identifier and batch number. Keep a batch record in your notes and medical chart; traceability labels appear in the ANMAT documentation. If someone refuses to show packaging, proposes material from an already opened syringe or will not identify the formula, it is reasonable to decline.
For which goals might it be worth considering?
A modest change in dryness, fine skin texture, elasticity or small superficial lines may be worth discussing with realistic expectations. PN injections do not reliably correct deep folds due to volume loss, excess skin, marked jowls or shifted tissues. Inflammatory breakouts, a sudden rash, pigmentation of uncertain cause and differing scar types need their own diagnosis first.
If you want to look like yourself, avoiding deliberate addition of substantial volume may appeal. But injections can still leave swelling or temporary irregularities. A natural-looking result depends on quantity, depth of injection and tissue condition. Compare skin feel and matched-lighting photos only after the agreed assessment interval, not the following day when post-injection swelling may create temporary fullness.
For mild dryness without substantial structural concerns, consider repairing the skin barrier first: gentle cleansing, moisturiser and daily sun protection. For deep folds, hyaluronic-acid fillers may be discussed as a different option with different aims and risks. Another PN brand, such as Plinest, cannot be assumed identical to Nucleofill; origin, concentration and supporting evidence must be checked separately.
When is it better not to inject, or to postpone?
For versions covered by the ANMAT documentation, contraindications include pregnancy, breastfeeding, age under 18, ingredient hypersensitivity, active infection and inflammation. That specific instruction also explicitly lists diabetes, epilepsy, circulatory disorders, active dermatitis, current herpes, past or present autoimmune disease, immunotherapy and multiple severe allergies. These are not blanket contraindications for every PN product: the clinician must review current instructions for the exact formula and your medical history. Disclose fish allergy and previous injection reactions before treatment.
Anticoagulants and medicines affecting clotting increase the chance of bruising or bleeding. The cited Argentinian instructions call for discontinuing anticoagulants at least 14 days beforehand in consultation with a doctor; this is not advice to stop essential treatment, which can be dangerous. Only the prescribing doctor should assess whether changing treatment is safe; if not, postpone the cosmetic injection. Also disclose other regular medicines, wound-healing problems, keloid scarring and recent laser treatment or peels.
The consultation should explain why injection, rather than observation or skincare, makes sense for your concern. A claim that it suits everyone without asking about allergies or medicines is a warning sign. A medical procedure is not a necessary next step after buying skincare; doing nothing is reasonable if you are comfortable with your skin.
What happens during injections, and what will show on my face?
After reviewing your history and skin, the clinician selects an area and technique, cleans it and applies antiseptic. Fine-needle injections can feel like repeated pricks, stinging or pressure; discuss topical anaesthetic beforehand if appropriate. There is no universal protocol for the face, neck and other sites, and the session count should follow individual assessment. An advertised fixed course does not explain why it is needed or when to stop.
Small raised injection points, redness, tenderness, swelling or bruises may appear immediately. Some settle quickly, but bruising and swelling can remain visible longer. Allow time before an important meeting or brightly lit photo shoot rather than planning on a flawless face the next morning. Unlike a treatment that leaves skin intact, injection marks cannot be guaranteed to be concealed safely with makeup straight away.
| When | What may happen | Practical choice |
|---|---|---|
| Injection day | Pinpricks, small papules, redness and sensitivity | Keep the evening free; cleanse gently as instructed |
| First several days | Swelling and bruises can remain; reactions usually begin settling | Do not rub the area or use aggressive skincare actives; ask about exercise |
| Following weeks | If a benefit occurs, skin-quality changes are assessed gradually | Compare matched photos, skin comfort and the need for further sessions without pressure |
ANMAT's published Nucleofill instructions advise avoiding cosmetics for 24 hours after injection and protecting the site from sun, ultraviolet exposure and temperature extremes while healing. Your treating clinician may give version-specific or individual directions. Do not massage injection sites on your own; if product distribution is indicated, a professional should follow the product instructions. Clarify when sport, sauna and acid-based skincare can resume before treatment.
How do I recognise an unwanted reaction?
Brief redness or tenderness after punctures can occur. Worsening pain, rapidly increasing swelling, hot red skin, pus, fever or a very painful lump require prompt medical contact. Sudden severe pain, white or blue discolouration, vision changes, breathing difficulty or signs of a serious allergy require immediate emergency help. These are safety precautions for injectable procedures; complication rates reported for other filler materials cannot be assigned to Nucleofill.
The same instructions expressly prohibit injection into blood vessels. The clinician should assess the relevant anatomy and have a plan for a suspected vascular complication.
Calling polynucleotides “biocompatible” does not mean zero risk. Local infection, hypersensitivity and nodular reactions are possible; uncommon or delayed harms for specific formulations are incompletely characterised. If you are uncertain, seek an independent in-person opinion and do not accept injections where no complication-management plan exists.
How can I compare offers without paying for promises?
Break the cost into the exact formula and amount used, treatment site, clinician qualifications and work, planned number of appointments, follow-up and complication arrangements. There is no verified universal price for Armenia, and “one syringe lasts forever” contradicts the procedure's temporary nature. Ask for a measurable objective such as comfort of dry skin or visibility of specific fine lines, not a vague “ten years younger”.
Testimonials do not substitute for independent research. Attractive photographs often fail to disclose lighting, retouching, other procedures or timing. If someone cites European certification or a clinical study, ask for documents matching your exact formulation and check which product was actually tested. Registration in one country cannot simply be carried over to another. This article has not established Nucleofill availability at any clinic in Yerevan; decide from product documents and personal medical assessment, not assumed access.
Further questions
Can Nucleofill be mixed with another injectable in the same syringe?
The published ANMAT instructions prohibit mixing the covered formulas with other injectable products. Any combined programme requires separate reasoning, intervals and product-specific instructions.
If I see no benefit after the first session, must I buy another?
No. Revisit the original goal, photographic conditions, observation period and alternatives first. Further injections should not be an obligation merely because the initial effect was modest.
Is Nucleofill suitable for someone avoiding animal-derived products?
The described formulations contain fish-derived animal polynucleotides. If that matters ethically or medically, tell your clinician and request an alternative with a documented ingredient source.
Sources
- ANMAT (Argentina): Nucleofill decision and instructions (2022)
- Nucleofill distributor: Medium and Strong product claims
- Systematic review of aesthetic polynucleotides (2025)
- Systematic review of randomized PN/PDRN trials (2026)
- British Cosmetic Dermatology Group: patient information (2026)
- FDA: general dermal filler risks; not Nucleofill authorization